Research & Development

Tsukuba Research Institute

The Tsukuba Research Institute carries out research and development primarily on diagnostic reagents in the fields of biochemistry, blood coagulation, diabetes, infections, and advanced techniques like genetic diagnosis; on reagents for automated analyzers utilizing enzymatic analysis and latex turbidimetric immunoassay; also point-of-care (POC) diagnostic reagents, to provide high-sensitivity and high-accuracy new products by virtue of the company's technology.

Tsukuba Diagnostics Development Center

To introduce the original research findings obtained by the Tsukuba Research Institute into medical laboratories around the world as clinical diagnostics, the Tsukuba Diagnostics Development Center is responsible for the development of highly reliable medical devices based on an international quality management system. These development activities include evaluation studies of clinical effectiveness and validation of the industrialization process on our products.

ADME & TOX. Research Institute establishes new drug evaluation systems to meet new drug development regulations related to pharmacokinetic tests, pioneers in the development of the state-of-art technologies, and implements such the state-of art technologies including licensed technologies into contract services.